Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.61 |
| ▸ | CA1 | P00915 | 5/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | Q9HBH1 | 1/20 | 0.40 | |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22304387 | 0.92 | CA2 (0.50) | CA2CA1MAPK1ALDH1A1PDF | |
| SCHEMBL2058687 | 0.90 | CA2 (0.68) | CA2CA1MAPK1USP2ALDH1A1 | |
| SCHEMBL25732354 | 0.89 | CA2 (0.66) | CA2CA1MAPK1USP2ALDH1A1 | |
| SCHEMBL12873393 | 0.84 | PDF (0.57) | CA2CA1PDF | |
| SCHEMBL11095965 | 0.81 | CA2 (0.66) | CA2CA1MAPK1USP2ALDH1A1 | |
| SCHEMBL9652484 | 0.81 | CA2 (0.56) | CA2CA1MAPK1USP2ALDH1A1 | |
| SCHEMBL21340001 | 0.80 | HDAC8 (0.56) | CA2CA1SMN1; SMN2LMNATSHR | |
| SCHEMBL24124963 | 0.79 | CA2 (0.53) | CA2CA1MAPK1USP2PDF | |
| SCHEMBL16389960 | 0.79 | CA2 (0.63) | CA2CA1MAPK1USP2ALDH1A1 | |
| SCHEMBL2058865 | 0.79 | CA2 (0.63) | CA2CA1MAPK1USP2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11607378-B2 | Cosmetic composition comprising amide-based compound | NEOPHARM CO., LTD. (KR) | 2023-03-21 | — | — | US | disclosed |
| US-11446223-B2 | Anti-aging composition | NEOPHARM CO., LTD. (KR) | 2022-09-20 | — | — | US | disclosed |
| CN-109843277-B | Anti-inflammatory composition | 株式会社新药 | 2022-08-02 | — | — | CN | disclosed |
| US-11285119-B2 | Anti-inflammatory composition | NEOPHARM CO., LTD. (KR) | 2022-03-29 | — | — | US | disclosed |
| US-20210283031-A1 | COSMETIC COMPOSITION COMPRISING AMIDE-BASED COMPOUND | NEOPHARM CO., LTD. (KR) | 2021-09-16 | — | — | US | disclosed |
| US-20210283031-A1 | COSMETIC COMPOSITION COMPRISING AMIDE-BASED COMPOUND | NEOPHARM CO., LTD. (KR) | 2021-09-16 | — | — | US | disclosed |
| CN-109069454-B | Anti-aging composition | 株式会社新药 | 2021-09-07 | — | — | CN | disclosed |
| EP-3431082-B1 | ANTI-AGING COMPOSITION | NEOPHARM CO LTD (KR) | 2021-06-09 | — | — | EP | disclosed |
| US-20200330352-A1 | ANTI-AGING COMPOSITION | NEOPHARM CO., LTD. (KR) | 2020-10-22 | — | — | US | disclosed |
| US-20190262287-A1 | ANTI-INFLAMMATORY COMPOSITION | NEOPHARM CO., LTD. (KR) | 2019-08-29 | — | — | US | disclosed |
| EP-3431082-A1 | ANTI-AGING COMPOSITION | Neopharm Co.,Ltd. (KR) | 2019-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11446223-B2 | Anti-aging composition | COL14A1, CUTA, COL2A1 | CA2 3119/4885CA1 4844/4885MAPK1 4040/4885 |
| US-11607378-B2 | Cosmetic composition comprising amide-based compound | CUTA, TYR, ARG1 | CA2 2908/4885CA1 4424/4885MAPK1 911/4885 |
| US-20190262287-A1 | ANTI-INFLAMMATORY COMPOSITION | TNF, CUTA, IL6 | CA2 4471/4885CA1 4655/4885MAPK1 2982/4885 |
| US-11285119-B2 | Anti-inflammatory composition | TNF, CUTA, IL6 | CA2 4471/4885CA1 4655/4885MAPK1 2982/4885 |
| US-20210283031-A1 | COSMETIC COMPOSITION COMPRISING AMIDE-BASED COMPOUND | CUTA, TYR, ARG1 | CA2 2908/4885CA1 4424/4885MAPK1 911/4885 |
| US-20200330352-A1 | ANTI-AGING COMPOSITION | COL14A1, CUTA, COL2A1 | CA2 3119/4885CA1 4844/4885MAPK1 4040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.